Other immune biomarkers, such as interleukin 8 (IL8) and LMR (lymphocyte-to-monocyte ratio) have also been identified as significant prognostic factors (10), suggesting the utility of immune system biomarkers in predicting the prognosis of CRC. Here, CXCL8 is linked to colorectal carcinoma.